Thursday, January 23, 2020
Breaking Medical Device Industry News
Home Accuracy Inc

Accuracy Inc

    The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System

    1/17/19: The system's unique design and advanced treatment planning software help enable physicians to avoid healthy tissue and minimize side effects on urinary, bowel, and sexual function that can reduce a man's quality of life.

    Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study

    5/22/18: "It was a great experience to compete with all available systems for SRS treatments," said Daniela Schmitt, PhD, department of radiation oncology, Heidelberg University Hospital. "We often use the CyberKnife to treat patients with multiple brain metastases and now have confirmation of our good clinical practice. Treatment planning studies like this can help the whole community to find the best solution with their systems and to achieve the best daily clinical treatment plans based on the lessons learned."

    South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System

    4/24/18: The CyberKnife platform specializes in delivering stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments with sub-millimeter precision.

    Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy With the CyberKnife® System

    3/27/18: New Clinical Trial Evaluates Use of Online-Adaptive Stereotactic Body Radiation Therapy Approach in the Treatment of Oligometastases

    New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers

    Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better...

    New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications

    Accuray Incorporated (NASDAQ: ARAY) announced today that studies continue to demonstrate the unmatched flexibility of the cutting-edge TomoTherapy® System to treat, with precision and...

    New Data Presented at ESTRO 36

    Accuray Incorporated announced that studies on the clinical use of the leading-edge CyberKnife® System continue to demonstrate its benefits across a wide range of...